The outcome suggested that regardless of age, gender, tumor size, depth of invasion, lymph node metastasis, degree of differentiation, venous invasion, neural invasion and TNM stage, high level FGF1 expression was associated with markedly shorter survival (Figure 3). This evidence concerns the gene FGF1 and metastatic malignant neoplasm in the lymph nodes.